GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » DeferredTaxAndRevenue

Acticor Biotech (XPAR:ALACT) DeferredTaxAndRevenue : €0.00 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Acticor Biotech's current deferred tax and revenue for the quarter that ended in Jun. 2023 was €0.00 Mil.

Acticor Biotech DeferredTaxAndRevenue Historical Data

The historical data trend for Acticor Biotech's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech DeferredTaxAndRevenue Chart

Acticor Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
DeferredTaxAndRevenue
Get a 7-Day Free Trial - - - - -

Acticor Biotech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only - - - - -

Acticor Biotech DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Acticor Biotech's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Acticor Biotech (XPAR:ALACT) Business Description

Traded in Other Exchanges
Address
82 Avenue du Maine, Wojo Building, Paris, FRA, 75014
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines